EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Camrelizumab combined with chemotherapy as postoperative adjuvant therapy after radical surgery for cervical cancer patients with pathologically positive lymph nodes: a prospective multicenter phase II clinical trial

Liqing Chen iD, Tingting Chen iD, Nalan Tu iD, Liya Dong iD, Yingli Zhang iD, Hui Wang iD, Yuanming Shen iD

Journal of Gynecologic Oncology · 2027 · 38

DOI: 10.3802/jgo.2027.38.e1 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Gynecologic Oncology, 2027. Verfasst von Liqing Chen und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gynecologic Oncology, Women's Hospital, Zhejiang University School of Medicine, Hangzhou, China. Die Arbeit nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Noncommunicable Chronic Disease-National Science and Technology Major Project, Natural Science Foundation of China, Natural Science Foundation of Zhejiang Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

Cervical CancerChemotherapyClinical TrialHysterectomyImmune Checkpoint InhibitorsLymph Node Metastases

Autor:innen und Institutionen

  • Department of Gynecologic Oncology, Women's Hospital, Zhejiang University School of Medicine, Hangzhou, China.
  • Zhejiang Provincial Clinical Research Center for Obstetrics and Gynecology, Hangzhou, China.
  • Zhejiang Provincial Key Laboratory of Precision Diagnosis and Therapy for Major Gynecological Diseases, Women's Hospital, Zhejiang University School of Medicine, Hangzhou, China.
  • Zhejiang Provincial Cancer Hospital, Hangzhou, China.
  • Zhejiang Provincial Key Laboratory of Precision Diagnosis and Therapy for Major Gynecological Diseases, Women's Hospital, Zhejiang University School of Medicine, Hangzhou, China. 5312010@zju.edu.cn.

ORCID-Profile: Liqing Chen, Tingting Chen, Nalan Tu, Liya Dong, Yingli Zhang, Hui Wang, Yuanming Shen

Förderung

  • Noncommunicable Chronic Disease-National Science and Technology Major Project
  • Natural Science Foundation of China
  • Natural Science Foundation of Zhejiang Province

Zitieren

APA

Chen, L., Chen, T., Tu, N., Dong, L., Zhang, Y., Wang, H., & Shen, Y. (2027). Camrelizumab combined with chemotherapy as postoperative adjuvant therapy after radical surgery for cervical cancer patients with pathologically positive lymph nodes: a prospective multicenter phase II clinical trial. Journal of Gynecologic Oncology, 38. https://doi.org/10.3802/jgo.2027.38.e1

Vancouver

Chen L, Chen T, Tu N, Dong L, Zhang Y, Wang H, et al. Camrelizumab combined with chemotherapy as postoperative adjuvant therapy after radical surgery for cervical cancer patients with pathologically positive lymph nodes: a prospective multicenter phase II clinical trial. Journal of Gynecologic Oncology. 2027;38. doi:10.3802/jgo.2027.38.e1

BibTeX
@article{Chen2027,
  author = {Chen, Liqing and Chen, Tingting and Tu, Nalan and Dong, Liya and Zhang, Yingli and Wang, Hui and Shen, Yuanming},
  title = {Camrelizumab combined with chemotherapy as postoperative adjuvant therapy after radical surgery for cervical cancer patients with pathologically positive lymph nodes: a prospective multicenter phase II clinical trial},
  journal = {Journal of Gynecologic Oncology},
  year = {2027},
  volume = {38},
  doi = {10.3802/jgo.2027.38.e1}
}
Kostenlos starten →